Potential Vaccines and Post-Exposure Treatments for Filovirus Infections
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential Vaccines and Post-Exposure Treatments for Filovirus Infections
Authors
Keywords
-
Journal
Viruses-Basel
Volume 4, Issue 9, Pages 1619-1650
Publisher
MDPI AG
Online
2012-09-21
DOI
10.3390/v4091619
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibodies for prevention and treatment of respiratory syncytial virus infections in children
- (2012) Bessey Geevarghese et al. ANTIVIRAL THERAPY
- Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever
- (2012) Andrea Marzi et al. PLoS One
- Recovery Potential of a Western Lowland Gorilla Population following a Major Ebola Outbreak: Results from a Ten Year Study
- (2012) Céline Genton et al. PLoS One
- Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
- (2012) J. M. Dye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
- (2012) X. Qiu et al. Science Translational Medicine
- Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
- (2012) Chad E. Mire et al. PLoS Neglected Tropical Diseases
- Identification of an antioxidant small-molecule with broad-spectrum antiviral activity
- (2011) Rekha G. Panchal et al. ANTIVIRAL RESEARCH
- Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies
- (2011) Xiangguo Qiu et al. CLINICAL IMMUNOLOGY
- Filovirius vaccines
- (2011) Steven B. Bradfute et al. Human vaccines & immunotherapeutics
- Inhibition of Ebola Virus Entry by a C-peptide Targeted to Endosomes
- (2011) Emily Happy Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Real-time Monitoring of Cardiovascular Function in Rhesus Macaques Infected With Zaire ebolavirus
- (2011) Mark G. Kortepeter et al. JOURNAL OF INFECTIOUS DISEASES
- Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
- (2011) Stephan Günther et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody-Dependent Enhancement of Marburg Virus Infection
- (2011) Eri Nakayama et al. JOURNAL OF INFECTIOUS DISEASES
- Filovirus Hemorrhagic Fever Outbreak Case Management: A Review of Current and Future Treatment Options
- (2011) Paul Roddy et al. JOURNAL OF INFECTIOUS DISEASES
- Ebolavirus -Peptide Immunoadhesins Inhibit Marburgvirus and Ebolavirus Cell Entry
- (2011) S. R. Radoshitzky et al. JOURNAL OF VIROLOGY
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
- (2011) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Identification of a Small-Molecule Entry Inhibitor for Filoviruses
- (2011) A. Basu et al. JOURNAL OF VIROLOGY
- Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
- (2011) J. E. Blaney et al. JOURNAL OF VIROLOGY
- A Single Sublingual Dose of an Adenovirus-Based Vaccine Protects against Lethal Ebola Challenge in Mice and Guinea Pigs
- (2011) Jin Huk Choi et al. MOLECULAR PHARMACEUTICS
- Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
- (2011) Marceline Côté et al. NATURE
- Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
- (2011) Jan E. Carette et al. NATURE
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana
- (2011) Waranyoo Phoolcharoen et al. PLANT BIOTECHNOLOGY JOURNAL
- Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant
- (2011) L. Zeitlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus
- (2011) A. S. Kondratowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice
- (2011) Krishnamurthy Konduru et al. VACCINE
- Correlates of Immunity to Filovirus Infection
- (2011) Steven Bradfute et al. Viruses-Basel
- A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus
- (2011) Yoshimi Tsuda et al. PLoS Neglected Tropical Diseases
- Alkylated Porphyrins Have Broad Antiviral Activity against Hepadnaviruses, Flaviviruses, Filoviruses, and Arenaviruses
- (2010) Haitao Guo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antiviral Activity of a Small-Molecule Inhibitor of Filovirus Infection
- (2010) T. K. Warren et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of heat-shock protein 90 reduces Ebola virus replication
- (2010) Darci R. Smith et al. ANTIVIRAL RESEARCH
- Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations
- (2010) Jens H. Kuhn et al. ARCHIVES OF VIROLOGY
- High-Content Assay to Identify Inhibitors of Dengue Virus Infection
- (2010) David Shum et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season
- (2010) Pilar Fernández et al. BMC Pediatrics
- Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector
- (2010) W. D. Pratt et al. Clinical and Vaccine Immunology
- Recent advances inEbolavirusvaccine development
- (2010) Jason S. Richardson et al. Human vaccines & immunotherapeutics
- High-Dose Mannose-Binding Lectin Therapy for Ebola Virus Infection
- (2010) Ian C. Michelow et al. JOURNAL OF INFECTIOUS DISEASES
- Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study
- (2010) Thomas W Geisbert et al. LANCET
- Advanced antisense therapies for postexposure protection against lethal filovirus infections
- (2010) Travis K Warren et al. NATURE MEDICINE
- A broad-spectrum antiviral targeting entry of enveloped viruses
- (2010) M. C. Wolf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
- (2010) J.E. Ledgerwood et al. VACCINE
- Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
- (2010) Joshua M. DiNapoli et al. VACCINE
- Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
- (2010) Alexander A. Bukreyev et al. VIROLOGY
- Lipidic Systems for In Vivo siRNA Delivery
- (2009) Sherry Y. Wu et al. AAPS Journal
- Chemical Modifications of Antisense Morpholino Oligomers Enhance Their Efficacy against Ebola Virus Infection
- (2009) D. L. Swenson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of a broad-spectrum antiviral with activity against Ebola virus
- (2009) M. Javad Aman et al. ANTIVIRAL RESEARCH
- Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus
- (2009) Xavier Pourrut et al. BMC INFECTIOUS DISEASES
- Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it
- (2009) Jeffrey E Lee et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Heat-shock Protein 90 Is Essential for Stabilization of the Hepatitis C Virus Nonstructural Protein NS3
- (2009) Saneyuki Ujino et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Niemann-Pick C1 Functions Independently of Niemann-Pick C2 in the Initial Stage of Retrograde Transport of Membrane-impermeable Lysosomal Cargo
- (2009) Stephen D. B. Goldman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deficiency of Niemann-Pick Type C-1 Protein Impairs Release of Human Immunodeficiency Virus Type 1 and Results in Gag Accumulation in Late Endosomal/Lysosomal Compartments
- (2009) Y. Tang et al. JOURNAL OF VIROLOGY
- Newcastle Disease Virus-Vectored Vaccines Expressing the Hemagglutinin or Neuraminidase Protein of H5N1 Highly Pathogenic Avian Influenza Virus Protect against Virus Challenge in Monkeys
- (2009) J. M. DiNapoli et al. JOURNAL OF VIROLOGY
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
- (2009) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Cholesterol Synthesis Inhibitor U18666A and the Role of Sterol Metabolism and Trafficking in Numerous Pathophysiological Processes
- (2009) Richard J. Cenedella LIPIDS
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
- (2009) Scott G Hansen et al. NATURE MEDICINE
- Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine
- (2009) Jason S. Richardson et al. PLoS One
- Discovery of Swine as a Host for the Reston ebolavirus
- (2009) R. W. Barrette et al. SCIENCE
- Human Ebola Outbreak Resulting from Direct Exposure to Fruit Bats in Luebo, Democratic Republic of Congo, 2007
- (2009) Eric M. Leroy et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections
- (2008) D. L. Swenson et al. Clinical and Vaccine Immunology
- Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
- (2008) Dana L Swenson et al. Expert Review of Vaccines
- Marine Natural Product Libraries for High-Throughput Screening and Rapid Drug Discovery
- (2008) Tim S. Bugni et al. JOURNAL OF NATURAL PRODUCTS
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates
- (2008) T. W. Geisbert et al. JOURNAL OF VIROLOGY
- Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium
- (2008) Emyr Lloyd-Evans et al. NATURE MEDICINE
- Cross-reactive HIV-1-neutralizing activity of serum IgG from a rabbit immunized with gp41 fused to IgG1 Fc: Possible role of the prolonged half-life of the immunogen
- (2008) Mei-Yun Zhang et al. VACCINE
- Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
- (2008) Alexander Bukreyev et al. VIROLOGY
- Protection against lethal challenge by Ebola virus-like particles produced in insect cells
- (2008) Yuliang Sun et al. VIROLOGY
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
- (2008) Thomas W. Geisbert et al. PLoS Pathogens
- Cell penetrating peptide conjugates of steric block oligonucleotides
- (2007) Bernard Lebleu et al. ADVANCED DRUG DELIVERY REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More